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Amsterdam and Rotterdam, the Netherlands; New York, New York;
and Vancouver, British Columbia, CanadaOBJECTIVES The current study evaluates the incremental value of transluminal attenuation
gradient (TAG), TAG with corrected contrast opaciﬁcation (CCO), and TAG with exclusion of calciﬁed cor-
onary segments (ExC) over coronary computed tomography angiogram (CTA) alone using fractional ﬂow
reserve (FFR) as the gold standard.
BACKGROUND TAG is deﬁned as the contrast opaciﬁcation gradient along the length of a coronary
artery on a coronary CTA. Preliminary data suggest that TAG provides additional functional information.
Interpretation of TAG is hampered by multiple heartbeat acquisition algorithms and coronary calciﬁca-
tions. Two correction models have been proposed based on either dephasing of contrast delivery by
relating coronary density to corresponding descending aortic opaciﬁcation (TAG-CCO) or excluding calci-
ﬁed coronary segments (TAG-ExC).
METHODS Eighty-ﬁve patients with intermediate probability of coronary artery disease were pro-
spectively included. All patients underwent step-and-shoot 256-slice coronary CTA. TAG, TAG-CCO,
and TAG-ExC analyses were performed followed by invasive coronary angiography in conjunction with
FFR measurements of all major coronary branches.
RESULTS Thirty-four patients (40%) were diagnosed with hemodynamically-signiﬁcant coronary
artery disease (i.e., FFR #0.80). On a per-vessel basis (n ¼ 253), 59 lesions (23%) were graded as hemo-
dynamically signiﬁcant, and the diagnostic accuracy of coronary CTA (diameter stenosis $50%) was
95%, 75%, 98%, and 54% for sensitivity, speciﬁcity, negative predictive value, and positive predictive
value, respectively. TAG and TAG-ExC did not discriminate between vessels with or without hemody-
namically signiﬁcant lesions (–13.5  17.1 HU [Hounsﬁeld units]  10 mm–1 vs. –11.6  13.3 HU  10
mm–1, p ¼ 0.36; and 13.1  15.9 HU  10 mm–1 vs. –11.4  11.7 HU  10 mm–1, p ¼ 0.77, respectively).
TAG-CCO was lower in vessels with a hemodynamically-signiﬁcant lesion (–0.050  0.051 10 mm–1 vs.
–0.036  0.034 10 mm–1, p ¼ 0.03) and TAG-ExC resulted in a slight improvement of the net reclassiﬁca-
tion index (0.021, p < 0.05).
CONCLUSIONS TAG did not provide incremental diagnostic value over 256-slice coronary CTA
alone in assessing the hemodynamic consequences of a coronary stenosis. Correction for temporal
nonuniformity of contrast delivery or exclusion of calciﬁed coronary segments slightly enhanced the
results. (J Am Coll Cardiol Img 2014;7:374–86) ª 2014 by the American College of Cardiology
Foundation
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375oronary computed tomography angiography of TAG, including its correction models, obtained
(CTA) is increasingly used as a noninvasiveA B B R E V I A T I O N S
A N D A C R O N YM S
CAC = coronary artery calcium
CAD = coronary artery disease
CCO = corrected contrast
opaciﬁcation
CTA = computed tomography
angiography
DS = diameter stenosis
ExC = excluding calciﬁed
coronary segments
FFR = fractional ﬂow reserve
HU = Hounsﬁeld units
ICA = invasive coronary
angiography
TAG = transluminal attenuation
gradient
TIMI = Thrombolysis In
Myocardial Infarctiondiagnostic imaging tool for detection and
exclusion of coronary artery disease (CAD)
(1–3). A well-recognized limitation of coronary
CTA, similar to the anatomical evaluation during
invasive coronary angiography (ICA), is its moder-
ate ability to assess the hemodynamic signiﬁcance of
a given coronary stenosis (4–6). Therefore, func-
tional evaluation of coronary lesions deemed sig-
niﬁcant by coronary CTA is warranted to avoid
excess referral for ICA and to guide revascularization
therapy in a judicious manner (6,7). Although
computed tomography (CT) stress perfusion and
coronary CTA-derived estimation of fractional ﬂow
reserve (FFRCT) based on computational ﬂuid dy-
namics have been developed for this purpose, these
methods require additional contrast/radiation expo-
sure or extremely complex off-line analysis, respec-
tively, hampering their implementation in routine
clinical practice (8–11). Alternatively, linear regres-
sion analysis of the attenuation gradient along the
course of a coronary artery has been proposed to
evaluate the functional relevance of a coronary lesion.
The rationale behind the transluminal attenuation
gradient (TAG) is that contrast opaciﬁcation should
fall off more rapidly in the presence of a functionally-
signiﬁcant stenosis (12). Preliminary data, obtained
using a 320-row CT, have shown incremental value
of TAG over coronary CTA assessment alone (13).
However, TAG interpretation is complicated by
multiple heartbeat acquisitions (64- to 256-slice CT)
resulting in a lack of temporal uniformity. In addi-
tion, distortions due to highly calciﬁed coronary
plaquesmay inﬂuence results. Two correctionmodels
have been proposed based on either dephasing of
contrast delivery by relating coronary density to cor-
responding descending aortic opaciﬁcation (TAG
corrected contrast opaciﬁcation [CCO]) or excluding
nonlinear values provoked by coronary calciﬁcations
(TAG excluding calciﬁed coronary segments [ExC])
(14,15). Studies that have evaluated these models
are scarce, and the results are conﬂicting (14–17). The
current study aims to explore the diagnostic potentialFrom the *Department of Cardiology, VU University Medical Center, Amst
Medicine, and PET Research, VU University Medical Center, Amsterdam,
tistics, VU University Medical Center, Amsterdam, the Netherlands; xDepart
Rotterdam, the Netherlands; jjInstitute for Cardiovascular Imaging, Weill-Co
York, New York; and the {Department of Medicine and Radiology, Universit
Dr. Nieman has received research support from Bayer HealthCare, Siemens M
Toshiba Medical Systems. Dr. Leipsic has received consulting fees from Hear
they have no relationships relevant to the contents of this paper to disclose.
Manuscript received October 15, 2013; revised manuscript received Decembwith a 256-slice CT scanner. Imaging results were
prospectively compared with ICA in conjunction
with invasive FFR.
METHODS
Patient population. A total of 91 patients with an
intermediate probability of CAD, determined ac-
cording to the criteria of Diamond and Forrester
(18), were prospectively enrolled. Exclusion criteria
were previous percutaneous coronary intervention,
coronary artery bypass graft surgery, a previous
myocardial infarction, atrial ﬁbrillation, second- or
third-degree atrioventricular block, impaired renal
function, symptomatic asthma, or pregnancy. Elec-
trocardiography and echocardiography conﬁrmed
normal global left ventricular systolic func-
tion and the absence of previous myocardial
infarction or regional wall motion abnor-
malities in all patients. The protocol con-
sisted of cardiac CT with coronary artery
calcium (CAC) score and coronary CTA,
followed by ICA in conjunction with
FFR measurements of all major coronary
branches within 5 days. Coronary CTAwas
not performed in case of persistent elevated
heart rate above 65 beats/min despite pre-
treatment with beta-blocking agents (n ¼
4). Two patients refused ICA after coronary
CTA. The study population, therefore,
comprised 85 patients. No cardiac events
were documented between coronary CTA
and ICA in these patients. The study was
approved by the ethics committee, and
written informed consent was obtained
from all patients.
Cardiac CT. Patients underwent CAC scoring and
coronary CTA on a 256-slice CT scanner (Philips
Brilliance iCT, Philips Healthcare, Best, the
Netherlands). A stable low heart rate <65 beats/min
was achieved prior to the scanning protocol, either
spontaneously or after administration of oral and/or
intravenous metoprolol. A standard scanningerdam, the Netherlands; yDepartment of Radiology, Nuclear
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376protocol was applied, with a section collimation of
2  128  0.625 mm, a gantry rotation time of 270
ms, a tube voltage of 120 kV, and a tube current of
55 to 150 mA (for CAC scoring) or 200 mA (for
coronary CTA). All scans were performed with
prospective electrocardiogram-gating (Step & Shoot
Cardiac, Philips Healthcare) at 75% of the R-R in-
terval. Coronary calciﬁcation was deﬁned as a plaque
with an area of 1.03 mm2 and a density $130
Hounsﬁeld units (HU). The CAC score was calcu-
lated according to the method described by Agatston
et al. (19). After CAC scoring, coronary CTA was
performed immediately after administration of sub-
lingual nitroglycerine. For visualization of the coro-
nary artery lumen, a bolus of 100 ml iobitridol
(XenetiX 350, Guerbet, Brussels, Belgium) was
injected intravenously (5.7 ml $ s–1) followed by a 50-
ml saline chaser. The scan was triggered, using an
automatic bolus-tracking technique with a region of
interest placed in the descending thoracic aorta, at a
threshold of 150 HU. All CT scans were analyzed on
a 3-dimensional workstation (Brilliance, Philips
Medical Systems) by an experienced radiologist and
cardiologist. The coronary tree was evaluated ac-
cording to a 16-segment coronary artery model
modiﬁed from that of the American Heart Associa-
tion (20); a $50% diameter stenosis (DS) was
deemed signiﬁcant. Image quality was determined on
a 3-point scale: poor, moderate, or good. The mean
radiation effective dose during CAC score and cor-
onary CTA was estimated using the dose-length
productmultiplied by 0.014 as conversion factor (21).
Transluminal attenuation gradient. TAG was
determined on an IntelliSpace Portal workstation
(version 5.0.0.20030, Philips). For all major coronary
branches on coronary CTA, the luminal centerline
was determined. Perpendicular cross-sectional im-
ages were constructed, and a circular region of in-
terest of 1.0 mm2 was manually positioned in the
luminal center. The mean HU were determined
within the region of interest. Measurements were
obtained at 5-mm intervals from the coronary ostium
to the distal segment (up to a cross-sectional area of
2.0 mm2 as described previously [13]). TAG,
expressed in HU  10 mm–1, was measured in the 3
major coronary branches matching the arteries
interrogated by FFR. Besides standard TAG
analysis, 2 correction models were applied: 1) TAG-
ExC, excluding excessive calciﬁed coronary segments
in order to maintain linearity of the gradient (14,17);
and 2) TAG-CCO, corrected for timing-dependent
perturbation of coronary contrast delivery associated
with multiple heart beat imaging of 256-slice coro-
nary CTA. Each luminal attenuation measurementwas normalized to the descending aortic attenuation
of the corresponding scanning cycle by dividing
the mean coronary HU by the mean aortic HU
(13,15,17). TAG-CCO is deﬁned as the gradient of
the quotient of the mean coronary HU and mean
aortic HU per 10 mm.
ICA and FFR. ICA imaging was performed with a
biplane or monoplane cardiovascular x-ray system
(Allura Xper FD 10/10, Philips Healthcare) in $2
orthogonal directions per evaluated coronary artery
segment. Prior to the contrast injection, 0.2 ml of
nitroglycerin was administered intracoronarily to
induce epicardial coronary vasodilation. Each major
coronary artery territory was routinely interrogated
by FFR except for occluded or subtotal lesions. The
operator refrained from FFR measurements in these
tight lesions due to the potential risk of inﬂicting
a coronary dissection by the pressure wire. The
FFR was measured using a 0.014-inch sensor-tipped
guidewire (Volcano Corporation, Rancho Cordova,
California), whichwas introduced through a 5- or 6-F
guiding catheter, calibrated, and advanced into the
coronary artery. Adenosine was infused intracor-
onarily (150 mg) in the right and left coronary artery
to inducemaximal coronary hyperemia (22). TheFFR
was calculated as the ratio of the mean distal intra-
coronary pressure, measured by the pressure wire, to
the mean arterial pressure measured by the coronary
catheter (23). A stenosis with>90% luminal diameter
reduction or with an FFR #0.80 was considered he-
modynamically signiﬁcant (6). The coronary tree
was divided into a 16-segment coronary artery mo-
del modiﬁed from the American Heart Association
(20). Quantitative coronary angiography was per-
formed on all coronary segments >1.5 mm in diam-
eter (Xcelera, Philips Healthcare). Two experienced
interventional cardiologists blinded to the coronary
CTA results interpreted all images and FFR signals.
TIMI (Thrombolysis In Myocardial Infarction)
ﬂow grade was assessed in each major coronary
artery.
Statistical analyses. Continuous variables are pre-
sented as mean  SD, whereas categorical variables
are expressed as actual numbers. TAG, TAG-ExC,
and TAG-CCO were determined as a linear regres-
sion coefﬁcient from the coronary ostium to the most
distally measured value per 10 mm. There were no
corrections performed for the interdependency of the
coronary data within 1 patient. Continuous variables
of TAG, TAG-ExC, and TAG-CCO between
groups were compared with the Mann-Whitney U
test because of non-normal distribution. A receiver-
operating characteristic curve analysis was used to
deﬁne optimal cutoff values based on the maximal
Table 2. Coronary Computed Tomography Angiography
Characteristics
Heart rate, beats/min 57  7
Radiation dose, mSv 4.97  0.89
Image quality
Good 73 (86)
Moderate 10 (12)
Poor 2 (2)
Coronary CTA DS $50%
Per patient (n ¼ 85) 52 (61)
Per vessel (n ¼ 253) 104 (41)
CAC score 141 (0–818)
Age- and sex-corrected percentile, % 66  37
Values are mean  SD, n (%), or median (interquartile range).
CAC ¼ coronary artery calcium; CTA ¼ computed tomography angiography;
DS ¼ diameter stenosis.
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377sum of speciﬁcity and sensitivity (Youden index) to
obtain the highest discriminatory value for TAG,
TAG-ExC, and TAG-CCO. Diagnostic perfor-
mance of coronary CTA, TAG, TAG-ExC, and
TAG-CCO for the diagnosis of obstructive CAD
compared with FFR was determined with sensitivity,
speciﬁcity, negative predictive value, and positive
predictive value, including their related 95% conﬁ-
dence intervals, on a per-vessel and -patient basis.
Incremental value of TAG, TAG-ExC, and TAG-
CCO to coronary CTA was determined with area
under the receiver-operating characteristic curve
analysis based on a combination of parameters in the
logistic regression model and the net reclassiﬁcation
index (24). The relations among the 3 TAG mo-
dalities were analyzed using linear regression analysis.
Intraobserver and interobserver variability of TAG
was determined with the intraclass correlation coef-
ﬁcient using a 2-way random effects model. A p value
<0.05 was considered statistically signiﬁcant. All
statistical analyses were performed using SPSS soft-
ware package (version 20.0, IBM SPSS Statistics,
Chicago, Illinois).
RESULTS
Baseline characteristics of the 85 included patients
are shown in Table 1.
Coronary CTA. Prior to coronary CTA, 14 patients
(16%) received additional oral metoprolol (range 50Table 1. Baseline Patient Characteristics (n [ 85)
Age, yrs 57.3  9.7
Male 51 (60)
Body mass index, kg $ m2 27.1  4.1
CAD risk factors
Hypertension 31 (37)
Hypercholesterolemia 32 (38)
Current or history of smoking 38 (45)
Family history of IHD 39 (46)
Diabetes 13 (16)
Medication
Aspirin 76 (89)
ACE inhibitors 16 (19)
Beta-blockers 54 (64)
Statins 72 (85)
Angiotensin-II receptor blockers 12 (14)
Calcium-channel blockers 31 (25)
Long acting nitrates 10 (12)
Values are mean  SD or n (%).
ACE ¼ angiotensin-converting enzyme; CAD ¼ coronary artery disease;
IHD ¼ ischemic heart disease.to 150 mg), and in 30 patients (35%), metoprolol
was administered intravenously (range 5 to 30 mg).
Sublingual nitroglycerin was given in 83 patients
(98%). All patients were in sinus rhythm with an
average heart rate of 57  7 min1, coronary CTA
characteristics are shown in Table 2. Fifty-two of 85
patients (61%) were diagnosed with obstructive
CAD (i.e., >50% DS in $1coronary artery) based
on coronary CTA results.
Invasive coronary angiography. All procedures and
FFR measurements were conducted without any
complications. Of the 255 vessels in 85 patients,
2 vessels with an intermediate stenosis were
excluded due to the inability to interrogate the artery
with FFR owing to tortuosity, resulting in a total
of 253 evaluated vessels. FFR measurements were
obtained in 230 of these 253 vessels (91%). The
operator refrained from FFR interrogation in 19
arteries (8%) due to the presence of a subtotal lesion,
and 3 lesions (1%) were chronic total occlusions
with collateral circulation from a native donor artery.
These 22 (sub)total lesions were considered hemo-
dynamically signiﬁcant (6). All patent arteries dis-
played TIMI ﬂow grade 3. In 1 vessel without an
apparent lesion, FFR was not obtained for techni-
cal reasons. This vessel was allocated to theTable 3. QCA DS at ICA (n [ 253)
<30% 137 (54)
30%–49% 57 (23)
50%–70% 22 (9)
>70% 37 (15)
Values are n (%).
DS ¼ diameter stenosis; ICA ¼ invasive coronary angiography;
QCA ¼ quantitative coronary angiography.
Figure 1. Example of TAG Analysis of a LAD With a Hemodynamically-Signiﬁcant Stenosis
Coronary computed tomography angiography (CTA) (A and C) and cross-sectional images with the region of interest indicated by the green
circle (D), invasive coronary angiography with FFR (B), and results of 3 transluminal attenuation gradient (TAG) analyses (E). Note the decrease
of contrast density along the coronary artery, which is compatible with the presence of an obstructive lesion in the left anterior descending
coronary artery (LAD) with a noncalciﬁed hemodynamically-signiﬁcant stenosis (fractional ﬂow reserve [FFR] ¼ 0.43). CCO ¼ corrected contrast
opaciﬁcation; ExC ¼ excluding calciﬁed coronary segments; HU ¼ Hounsﬁeld units; HUa ¼ aortic Hounsﬁeld units; HUc ¼ coronary Hounsﬁeld
units.
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378nonsigniﬁcant group. On a per-patient basis, 34
(40%) displayed$1 vessel with FFR#0.80, whereas
on a per-vessel basis, 59 lesions (23%) were hemo-
dynamically signiﬁcant. Quantitative coronary angi-
ography diameter stenosis per vessel analysis is shown
in Table 3.
Transluminal attenuation gradient. TAG, TAG-
ExC, and TAG-CCO were measured in all 253
vessels, regardless of the presence of CAD or image
quality (good to moderate in 98%) (Table 2, Figs. 1
and 2). Subgroup analysis was performed in vessels
with a coronary CTA-based DS $50%. Table 4
lists mean TAG parameters and differentiationbetween vessels with or without coronary CTA-
graded signiﬁcant lesions. Although all 3 TAG an-
alyses showed on average a slightly lower value for
the vessels containing a hemodynamically signiﬁcant
stenosis, statistical signiﬁcance was only achieved
for TAG-CCO (p¼ 0.03). When subgroup analysis
of vessels with a coronary CTA-based DS $50%
was performed, TAG-CCO was no longer signiﬁ-
cant (n ¼ 104, p ¼ 0.07). Figure 3 shows the cor-
relation between different TAG parameters. All
correlations were highly signiﬁcant (p < 0.001).
Diagnostic accuracy of coronary CTA diameter
stenosis and TAG. Table 5 summarizes the diagnostic
Figure 2. Example of TAG Analysis of a LAD Without Stenosis
Coronary CTA (A and C) and cross-sectional images with the region of interest indicated by the green circle (D), invasive coronary angi-
ography with FFR (B), and TAG analyses (E) of a normal left anterior descending coronary artery without stenosis (FFR ¼ 0.93). Note that TAG
values are in the same order of magnitude as the patient with an ischemic lesion as depicted in Figure 1. Abbreviations as in Figure 1.
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379accuracy of CT parameters. A DS$50% was used as
a cutoff value for coronary CTA, whereas optimal
thresholds for TAG, TAG-ExC, and TAG-CCO
were derived from receiver-operating characteristic
curve analyses. Diagnostic accuracy of coronary CTA
was distinctly superior to any TAG modality. The
area under the curve at receiver-operating character-
istic analyses for TAG, TAG-ExC, and TAG-CCO
did not signiﬁcantly differ from the line of identity
(p > 0.05 for all).
Incremental value of TAG in addition to coronary CTA
DS for predicting FFR #0.80. Figure 4 illustrates
the incremental value of the TAG parameters to the
diagnostic value of coronary CTADS alone. None ofthe added TAG parameters raised the area under the
curve of coronary CTA DS analysis. Table 6 lists the
diagnostic accuracy of coronary CTA in conjunction
with each of the TAG modalities and net reclassiﬁ-
cation indexes. Although differences were minute,
TAG-ExC had a signiﬁcant impact on coronary
CTA alone and resulted in 4 correct reclassiﬁcations
(1.6%) from false positive to true negative (net
reclassiﬁcation improvement index ¼ 0.021, p ¼
0.046). Net reclassiﬁcation indexes were not signif-
icant for TAG and TAG-CCO.
Impact of plaque composition on TAG. Figure 5
displays an example of a patient with heavily calci-
ﬁed coronary plaques, potentially hampering reliable
Table 4. TAG Analyses on a Per-Vessel Basis and Subgroup Analysis for Coronary CTA Signiﬁcant (DS ‡50%) Vessels
Average FFR >0.80 FFR £0.80
Between FFR Groups,
p Value*
All vessels 253 194 59
TAG, HU  10 mm–1 –11.6  13.3 –11.1  11.8 –13.5  17.1 0.36
TAG-ExC, HU  10 mm–1 –11.8  12.8 –11.4  11.7 –13.1  15.9 0.77
TAG-CCO, 10 mm–1 –0.039  0.039 –0.036  0.034 –0.050  0.051 0.03
Coronary CTA DS $50% 104 48 56
TAG, HU  10 mm–1 –11.3  15.3 –9.0  12.3 –13.3  17.3 0.17
TAG-ExC, HU  10 mm–1 –11.6  14.2 –10.1  11.7 –12.9  16.0 0.36
TAG-CCO, 10 mm–1 –0.042  0.045 –0.034  0.037 –0.049  0.051 0.07
Values are n or mean  SD. *The p values are determined using the Mann-Whitney U test.
CCO ¼ corrected contrast opaciﬁcation; ExC ¼ excluding calciﬁed coronary segments; FFR ¼ fractional ﬂow reserve; HU ¼ Hounsﬁeld units; TAG ¼ transluminal
attenuation gradient; other abbreviations as in Table 2.
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380TAG analysis. Subgroup analysis according to the
presence and severity of plaque calciﬁcation is sum-
marized in Table 7 (calciﬁed vs. noncalciﬁed or
partially calciﬁed), with additional subgroup analyses
for coronary CTA-positive and -negative vessels.
Eighty-six of 253 vessels were deﬁned as calciﬁed,
whereas 167 vessels were deﬁned as noncalciﬁed or
partially calciﬁed. There was no signiﬁcant differ-
ence of TAG, TAG-ExC, or TAG-CCO between
vessels with severely calciﬁed plaques and no or
partially calciﬁed plaques.
Intraobserver and interobserver variability for TAG.
TAG measurements were stable and reproducibleFigure 3. Scatter Plot Showing the Relations Among TAG, TAG-CCO
Correlations of TAG, TAG-CCO, and TAG-ExC were highly signiﬁcant (pwithin and between observers in 25 randomly
selected vessels. Corresponding intraclass correla-
tion coefﬁcients for single measures were 0.91 (p <
0.001) and 0.85 (p < 0.001) for intraobserver and
interobserver variability, respectively.
D I SCUSS ION
The current study was conducted to evaluate the
potential of TAG to assess the hemodynamic con-
sequences of coronary stenoses diagnosed by
coronary CTA. The results demonstrate that TAG
does not evidently improve the diagnostic accuracy, and TAG-ExC
< 0.001 for all correlations). Abbreviations as in Figure 1.
Table 5. Diagnostic Accuracy (95% CI) of Coronary CTA, TAG, TAG-ExC, and TAG-CCO for Predicting FFR £0.80 on a Per-Patient
and -Vessel Basis (Both for All and Coronary CTA-Positive Vessels Only)
Coronary CTA
TAG,
HU 3 10 mmL1
TAG-ExC,
HU 3 10 mmL1
TAG-CCO,
10 mmL1
Per-vessel basis (n ¼ 253) DS $50% #–7.51 #–7.36 #–0.035
Sensitivity, % 95 (86–99) 69 (56–81) 64 (51–76) 63 (49–75)
Speciﬁcity, % 75 (69–81) 44 (37–52) 44 (37–51) 54 (46–61)
NPV, % 98 (94–100) 83 (74–90) 80 (71–87) 83 (75–89)
PPV, % 54 (44–64) 27 (21–35) 26 (19–34) 29 (22–38)
Per-patient basis (n ¼ 85) DS$50% #–7.51 #–7.36 #–0.035
Sensitivity, % 100 (100) 91 (76–98) 91 (76–98) 91 (76–98)
Speciﬁcity, % 65 (50–78) 16 (7–29) 14 (6–26) 20 (10–33)
NPV, % 100 (100) 73 (39–94) 70 (35–93) 77 (46–95)
PPV, % 65 (50–78) 42 (31–54) 41 (30–53) 43 (31–55)
Coronary CTA signiﬁcant vessels (n ¼ 104) #–7.51 #–3.29 #–0.025
Sensitivity, % NA 70 (56–81) 84 (72–92) 77 (64–87)
Speciﬁcity, % NA 52 (37–67) 33 (20–48) 44 (30–59)
NPV, % NA 60 (43–74) 64 (43–82) 62 (44–78)
PPV, % NA 62 (50–75) 59 (48–70) 61 (49–73)
CI ¼ conﬁdence interval; NA ¼ not applicable; NPV ¼ negative predictive value; PPV ¼ positive predictive value; other abbreviations as in Tables 2 and 4.
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381over 256-slice coronary CTA alone to diagnose
hemodynamically-signiﬁcant lesions by ICA/FFR.
Exclusion of calciﬁed coronary plaques or correction
for arterial phase-dependent contrast density levels
between heartbeats during image acquisition did
inﬂuence TAG results; however, it did not enhance
its diagnostic performance on a clinically-relevant
basis.
Coronary CTA. Using a DS threshold of 50%, cor-
onary CTA displayed an excellent sensitivity and
negative predictive value on a per-vessel and -pa-
tient basis, whereas speciﬁcity and positive predic-
tive value were moderate at best to diagnose
functional CAD. Although numerous studies have
evaluated the diagnostic accuracy of coronary CTA
(1–3,25), this is one of the few investigations that
have systematically used FFR as a reference tech-
nique in a prospective manner (9,26). In line with
these studies, 35% of patients with a signiﬁcant
angiographic stenosis at coronary CTA did not
exhibit functional CAD when evaluated with inva-
sive FFR, whereas not a single patient with a
negative coronary CTA displayed functional CAD
on ICA. These data conﬁrm the widely regarded
notion that coronary CTA can accurately rule out
CAD but requires additional functional testing in
case of an equivocal or abnormal result.
Transluminal attenuation gradient. In an effort to
retrieve functional information from a routinecoronary CTA, TAG has been suggested as a
method to evaluate the hemodynamic consequences
of a coronary lesion and to enhance the diagnostic
performance of coronary CTA alone (13,14). The
current data, however, did not reveal any differences
in TAG values between FFR-positive and -negative
lesions. On average, linear regression analysis of
the contrast density along a functionally signiﬁcant
coronary stenosis did display a decline of 13.5 
17.1 HU  10 mm–1, yet, a physiological density
drop in nearly the same order of magnitude was
observed in vessels that were not functionally
affected (11.1  11.8 HU  10 mm–1). Such a fall
in contrast density along the length of a non-
obstructed coronary has previously been docu-
mented by the work of Steigner et al. (27), although
an exacerbated decline of TAG was observed in
patients with a single signiﬁcant lesion in the left
anterior descending coronary artery. As in the cur-
rent study, reproducibility of measurements was
proven to be high and relatively independent of
heart rate, body mass index, or cardiac phase. The
relatively steep diminution of contrast density distal
to a coronary lesion has been linked to a reduction
in basal coronary ﬂow (28). To validate this concept,
using a 64-slice device, Choi et al. (14) retrospec-
tively selected 126 patients with a chronic total
coronary occlusion in $1 vessel. The investigators
observed a gradual decline in TAG with decreasing
Figure 4. Diagnostic Performance of Coronary CTA Alone and With TAG, TAG-ExC,
and TAG-CCO
Receiver-operating characteristic (ROC) curve analysis with corresponding area under the
curve (AUC) and 95% conﬁdence interval (CI) displaying the diagnostic performance of
coronary CTA, coronary CTA and TAG, coronary CTA and TAG-ExC, and coronary CTA and
TAG-CCO for the detection of hemodynamically-signiﬁcant coronary artery disease as
indicated by FFR. Abbreviations as in Figure 1.
Table 6. Incremental
CTA for Predicting F
Sensitivity, %
Speciﬁcity, %
NPV, %
PPV, %
NRI
p value NRI
NRI ¼ net reclassiﬁcation
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382TIMI ﬂow rate as observed during ICA, although a
large overlap between groups existed. In general,
however, such angiographic ﬁndings are infrequent
in a prospective patient population without a prior
cardiac history and an intermediate likelihood for
CAD for whom coronary CTA is considered to be
most appropriate (29). Thus, such a study design
may be suitable to act as a proof of principle, but it
yields results that are not applicable to a clinically-
relevant cohort of patients. Indeed, in the currentDiagnostic Value (95% CI) of TAG in Addition to Coronary
FR £0.80 on a Per-Vessel Basis (n [ 253)
Coronary
CTA D TAG
Coronary
CTA D TAG-ExC
Coronary
CTA D TAG-CCO
95 (86–99) 95 (86–99) 95 (86–99)
76 (69–82) 77 (71–83) 76 (69–82)
98 (94–100) 98 (94–100) 98 (94–100)
54 (44–64) 56 (46–66) 54 (44–64)
0.005 0.021 0.005
0.32 0.046 0.32
improvement index; other abbreviations as in Tables 2, 4, and 5.study population, only 3 chronic total occlusions with
collateral ﬂow were visualized during ICA, and all of
the patent arteries displayed TIMI ﬂow grade 3.
Subsequently, 2 64-row CT studies have compared
TAG with FFR, and similar to the present study,
they used an FFR cutoff of 0.80 as a reference
standard. Yoon et al. (17) selected 53 patients and,
on exclusion of nonevaluable segments, identiﬁed 82
arteries of which 32 had a positive FFR. Although
statistically signiﬁcant, the area under the curve for
TAG was only 0.63 with an optimal cutoff value of
–6.5 HU  10 mm–1. In another study, Choi et al.
(16) retrospectively selected 65 patients with a pos-
itive coronary CTA with matching ICA and FFR
measurements where appropriate. In line with Yoon
et al. (17), diagnostic accuracy of TAGwas moderate
at best with an area under the curve of 0.70 and an
optimal threshold of –6.5 HU  10 mm–1. None-
theless, there was some incremental value of TAG
over coronary CTA alone. These studies, however,
were retrospective in nature, biased in patient selec-
tion, and excluded nondiagnostic segments. The
current study is the ﬁrst prospective 256-row CT
study with an intention to evaluate all segments,
irrespective of imaging quality or lesion characteris-
tics. Comparable with the aforementioned studies,
optimal TAG cutoff was –7.51 HU  10 mm–1, yet
the area under the curve did not appreciably diverge
from the line of identity.Moreover, TAGdid not add
incremental value to the diagnostic accuracy of cor-
onary CTA alone. It therefore appears that the pre-
viously demonstrated limited value of TAG as
observed in retrospective analysis is no longer present
in a prospective study design.
Correction temporal nonuniformity of contrast
delivery and for coronary calciﬁcation. A limitation
of the current and the aforementioned studies is
that images were obtained using CT equipment
that requires multiple heartbeats to cover the
entire heart. During post-processing, these images of
successive beats are stitched together. Consequently,
different segments of the artery from proximal to
distal lack temporal uniformity of contrast opaciﬁ-
cation. To resolve this issue, Chow et al. (15) pro-
posed CCO, whereby intracoronary contrast density
is divided by the density level of the descending aorta
in the same axial plain. CCO is then deﬁned as the
quotient of this value obtained proximal and distal of
a coronary lesion. Chow et al. (15) performed a
proof-of-concept study using a 64-slice CT in 52
patients selected on the basis of an abnormal coro-
nary CTA. CCO was signiﬁcantly lower in arteries
with impaired resting ﬂow (TIMI ﬂow grade <3 at
ICA), but they could not distinguish signiﬁcantly
Figure 5. Example of TAG Analysis of a Highly-Calciﬁed RCA
Coronary CTA (A and C) and cross-sectional images with the region of interest indicated by the green circle (D), invasive coronary angi-
ography with FFR (B), and TAG analyses (E) of a highly calciﬁed right coronary artery (RCA) with a hemodynamically signiﬁcant stenosis (FFR ¼
0.27). Note that TAG analyses were comparable and omission of calciﬁed segments did not alter the results. In this patient, TAG did not show a
decline in contrast density along the artery despite a severely compromised hyperemic distal pressure. Abbreviations as Figure 1.
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383stenosed from nonsigniﬁcantly stenosed vessels in
case of TIMI ﬂow grade 3. Choi et al. (16) were
subsequently unable to establish an enhanced diag-
nostic accuracy of CCO over conventional TAG,
both of which added no surplus value to coronary
CTA. In an effort to optimize results, in the current
study, CCO was calculated using linear regression of
CCO values along the coronary as employed with
TAG (TAG-CCO). Although TAG-CCO was
lower in arteries with a positive FFR (–0.036 0.034
 10 mm1 vs. –0.050  0.051  10 mm1,
p ¼ 0.03), there was a large overlap between FFR
groups, and TAG-CCO did not increase diagnosticaccuracy of coronary CTA alone. To circumvent the
issue of temporal uniformity, Wong et al. (13)
recently used TAG with a single-beat acquisition of
a 320-row CT system in a retrospective cohort of
patients. They reported a potential incremental value
of TAG; clearly, more TAG studies on such devices
that acquire the entire heart volume within a single
beat are warranted.
It has been suggested that omission of heavily-
calciﬁed segments that disrupt the linear regression
analysis on which TAG is based may improve re-
sults (14). Therefore, TAG analysis excluding these
calciﬁed segments was additionally performed. This
Table 7. Inﬂuence of Plaque Composition on TAG
Coronary CTA Plaque Composition
All (n [ 253)
TAG,
HU 3 10 mm–1
TAG-ExC,
HU 3 10 mm–1
TAG-CCO,
10 mm–1
Calciﬁed (n ¼ 86) –10.8  14.6 –10.9  13.0 –0.040  0.043
Noncalciﬁed/partially calciﬁed (n ¼ 167) –12.1  12.6 –12.2  12.7 –0.039  0.037
p value* 0.68 0.40 0.44
Coronary CTA DS $50% (n ¼ 104) –11.4  15.3 –11.6  14.2 –0.042  0.046
Calciﬁed (n ¼ 52) –10.7  17.6 –11.0  15.5 –0.042  0.051
Noncalciﬁed/partially calciﬁed (n ¼ 52) –12.0  12.7 –12.3  12.9 –0.042  0.039
p value* 0.70 0.43 0.76
Coronary CTA DS #50% (n ¼ 149) –11.8  11.7 –11.9  11.7 –0.038  0.034
Calciﬁed (n ¼ 34) –10.9  8.0 –10.9  8.0 –0.037  0.025
Noncalciﬁed/partially calciﬁed (n ¼ 115) –12.1  12.6 –12.2  12.6 –0.038  0.036
p value* 0.95 0.87 0.64
Values are mean  SD. *The p values are calculated using the Mann-Whitney U test between the calciﬁed and noncalciﬁed/partially calciﬁed groups.
Abbreviations as in Tables 2 and 4.
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384analysis, however, did not alter the results. In fact,
and as depicted in Figure 3, TAG correlated highly
with both TAG-ExC and TAG-CCO, and these
parameters appeared to be interchangeable. Finally,
given the high sensitivity and negative predictive
value of coronary CTA, TAG may only be useful in
obstructive vessels to enhance the low speciﬁcity and
positive predictive value. Some of the aforemen-
tioned retrospective studies may, in fact, have more
accurately identiﬁed the obstructive-vessel patients
who might beneﬁt from this approach. Subgroup
analysis in CT-based abnormal arteries in the current
study, however, did not alter the results, and TAG
remained unable to discriminate hemodynamically-
signiﬁcant from non–ﬂow-limiting stenoses.
From a theoretical point of view, these observa-
tions are not entirely unanticipated. A fall in con-
trast opaciﬁcation beyond a stenosis reﬂects impaired
resting ﬂow (27), whereas multiple studies have
clearly demonstrated that resting ﬂow remains
stable until the point of subtotal coronary occlusion
(30–32). Therefore, TAG appears to bemost suitable
to detect subtotal occlusions with TIMI ﬂow rates
<3 or total occlusions with a collateral circulation.
Study limitations. It must be acknowledged that
comparison between the current and previous studies
on the value of TAG is hampered by differences in
scan technology and acquisition. Most studies have
used 64-row devices with helical acquisition mode,
whereas the current study has used step-and-shoot
256-slice CT. Moreover, initiation of the CT
acquisition was triggered by bolus tracking of the
descending aorta, whereas previous studies were
based on acquisition timing after test bolus tracking.These factors may result in discrepancies of coronary
contrast concentrations, which may affect the TAG
results. Furthermore, signal magnitude is dependent
on tube voltage and milliamperes. Different scan
settings between studies may have been inﬂuencing
factors.
The sample size of the current study was relatively
small and, therefore, did not provide deﬁnite evi-
dence of the limited additional value of TAG over
coronary CTA. Larger studies are needed to provide
more insight into this matter. The use of 320-slice
or high-pitch dual-source CT equipment will also
be pivotal in these studies, overcoming the short-
comings of temporal nonuniformity of contrast
delivery by single-beat acquisitions.
With respect to missing FFR values, some as-
sumptions were made. A stenosis of >90% was
considered hemodynamically signiﬁcant, although
no FFR was provided. The operator refrained from
FFR measurements due to a potential risk of causing
pressure wire–related complications. Anatomical
lesion severity is known for its inability to provide
accurate functional information; however, Tonino
et al. (6) showed FFR to be #0.80 in 96% of all
lesions with a severity of 91% to 99%.
Intracoronary adenosine administration was
used in the current study protocol to achieve
vasodilation during FFR measurements, whereas
intravenous administration of 140 mg/kg/min is
generally considered the reference standard (33).
Although the utilized dosage of 150 mg intra-
coronary agrees well with intravenous administra-
tion (22), some studies have reported more potent
vasodilation with higher doses ranging from 300 to
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385600 mg that, therefore, may have yielded different
results (34,35).
CONCLUS IONS
In the current prospective cohort of patients with
an intermediate likelihood for CAD, TAG did not
provide incremental diagnostic value over 256-slice
coronary CTA alone in assessing the hemodynamic
consequences of a coronary stenosis. Correction fortemporal nonuniformity of contrast delivery or
exclusion of calciﬁed coronary segments slightly
enhanced the results, although the clinical impact
of these parameters appears to be limited.
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